We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$26.3B
AUM Growth
+$9.24B
Cap. Flow
+$7.53B
Cap. Flow %
28.64%
Top 10 Hldgs %
18.46%
Holding
4,036
New
995
Increased
1,114
Reduced
953
Closed
874

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.06B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$196M
3
Z icon
Zillow
Z
+$118M
4
ABNB icon
Airbnb
ABNB
+$106M
5
SNAP icon
Snap
SNAP
+$84.4M

Sector Composition

Rank Sector Weight
1 Technology 8.67%
2 Consumer Discretionary 8.07%
3 Healthcare 5%
4 Communication Services 4.51%
5 Industrials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCT icon
3201
Arcturus Therapeutics
ARCT
$157M
-8,609
Closed -$356K
ARCO icon
3202
Arcos Dorados Holdings
ARCO
$1.73B
-121,830
Closed -$611K
ARGX icon
3203
argenx
ARGX
$57.4B
-1,817
Closed -$500K
ARKO icon
3204
ARKO Corp
ARKO
$890M
-60,318
Closed -$600K
ARQT icon
3205
Arcutis Biotherapeutics
ARQT
$3.42B
-10,649
Closed -$308K
EFOR
3206
Everforth Inc
EFOR
$845M
-3,092
Closed -$295K
ASIX icon
3207
AdvanSix
ASIX
$567M
-8,091
Closed -$217K
ASMB icon
3208
Assembly Biosciences
ASMB
$506M
-2,883
Closed -$159K
ASTC icon
3209
Astrotech Corp
ASTC
$14.5M
-398
Closed -$26K
ASYS icon
3210
Amtech Systems
ASYS
$278M
-28,420
Closed -$336K
CVSA
3211
Covista Inc
CVSA
$3.94B
-6,301
Closed -$249K
ATRA icon
3212
Atara Biotherapeutics
ATRA
$71.2M
-4,754
Closed -$1.71M
AUDC icon
3213
AudioCodes
AUDC
$244M
-16,018
Closed -$432K
AUTL
3214
Autolus Therapeutics
AUTL
$386M
-82,602
Closed -$473K
AVTX icon
3215
Avalo Therapeutics
AVTX
$976M
-9
Closed
FABC
3216
Fabric.AI Inc
FABC
$16.8M
-318
Closed -$264K
AZN icon
3217
AstraZeneca
AZN
$263B
-52,894
Closed -$5.26M
AZO icon
3218
CALL
AutoZone
AZO
$48.3B
-300
Closed -$421K
AZO icon
3219
PUT
AutoZone
AZO
$48.3B
-3,300
Closed -$4.63M
BC icon
3220
Brunswick
BC
$5.19B
-2,198
Closed -$210K
BCDA icon
3221
BioCardia
BCDA
$12.7M
-3,130
Closed -$204K
BCRX icon
3222
BioCryst Pharmaceuticals
BCRX
$2.37B
-56,770
Closed -$577K
BDTX icon
3223
Black Diamond Therapeutics
BDTX
$101M
-59,863
Closed -$1.45M
BEKE icon
3224
KE Holdings
BEKE
$16.8B
-50,035
Closed -$2.85M
BF.B icon
3225
Brown-Forman Class B
BF.B
$12B
-116,791
Closed -$8.05M

Similar funds

Squarepoint's Q2 2021 Portfolio in Review

As of Q2 2021, Squarepoint held 4,036 positions worth $26.3B, up 54% from $17.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint deployed $7.53B of net new capital in Q2 2021, opening 995 new positions and adding to 1,114 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 633,432 shares worth $64.9M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $928M trimmed.

  • Squarepoint's largest Q2 2021 buy was State Street Industrial Select Sector SPDR ETF: 633,432 shares worth $64.9M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.06B increase.
  • Squarepoint's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $928M.
  • Squarepoint fully exited Block Inc in Q2 2021, selling an estimated $50M.
  • Squarepoint's ten largest holdings make up 18% of its $26.3B portfolio in Q2 2021.
  • Squarepoint opened 995 new positions and closed 874 in Q2 2021.
  • Squarepoint's portfolio value rose 54% quarter-over-quarter to $26.3B.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.